Skip to content

RNTX RNTX Accrued Expenses

Accrued Expenses at other companies

CTO
Citius Oncology, Inc.CTOR
$4.06M-53.4%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$7.46M-5.1%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$226K-0.9%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$74.84M+33.7%
Tenet Healthcare logo
Tenet HealthcareTHC
$854M+20.3%
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's accrued expenses?
RNTX (RNTX) reported accrued expenses of $2.45M in Q1 2026.
How has RNTX's accrued expenses changed year-over-year?
RNTX's accrued expenses decreased by 49.2% year-over-year, from $4.83M to $2.45M.
What is the long-term trend for RNTX's accrued expenses?
Over 5 years (2020 to 2025), RNTX's accrued expenses has grown at a 0.1% compound annual growth rate (CAGR), from $2.2M to $2.2M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.